Amsterdam Reproduction & Development

Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis (QUESTA study)

Trommelen, L. M., Semmler, A., de Bruijn, A. M., Harmsen, M., Smink, M., Janssen, P. F., van Rooij, I., van Bavel, J., Geomini, P., Maas, J. W. M., Radder, C. M., van Kesteren, P., Kwee, J., Bakkum, E., de Lange, M., de Leeuw, R. A., Groenman, F., Mijatovic, V., Timmermans, A. & Lely, R. & 21 others, Lamers, A., Vos, D., van Hoecke, G., Elgersma, O., van Vliet, H. A. A. M., Yo, L. S. F., Twijnstra, A. R. H., Jansen, F. W., van Rijswijk, C. S. P., Kruimer, H., Tseng, C. M. E. S. N., Coppus, S., Arntz, M., Wust, A. F. J., Blomjous, J. G. A. M., van Boven, L., Venmans, A., Twisk, J. W. R., Huirne, J. A. F., Lohle, P. N. M. & Hehenkamp, W. J. K., Aug 2025, In: Acta Obstetricia et Gynecologica Scandinavica. 104, 8, p. 1558-1574 17 p.

Research output: Contribution to journal › Article* › Academic › peer-review

Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids

de Lange, M. E., Semmler, A., Drenth, J. P. H., Vermeer, N. S., Bet, P. M., Huirne, J. A. F. & Hehenkamp, W. J. K., Mar 2025, In: Therapeutics and clinical risk management. 21, p. 367-382 16 p.

Research output: Contribution to journal › Review article* › Academic › peer-review

Considerations on implementation of the newest treatment for symptomatic uterine fibroids: Oral GnRH antagonists: Oral GnRH antagonists

de Lange, M. E., Semmler, A., Mol, B. W. J., Bet, P. M., Huirne, J. A. F. & Hehenkamp, W. J. K., 31 Aug 2023, In: British Journal of Clinical Pharmacology. 90, 2, p. 392-405 14 p.

Research output: Contribution to journal › Article* › Academic › peer-review